These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4664567)

  • 21. Letter: Vitamin E treatment of dermolytic bullous dermatoses.
    Reed WB
    Arch Dermatol; 1975 Apr; 111(4):524. PubMed ID: 164837
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidermolysis bullosa dystrophica (dermolytic bullous dermatosis).
    Kennedy C
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1240-1. PubMed ID: 4449869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidermolysis bullosa and collagenoses].
    Cozzani E; Gnone M; Arioni C; Cipriani C
    G Ital Dermatol Venereol; 1989 Sep; 124(9):397-402. PubMed ID: 2561397
    [No Abstract]   [Full Text] [Related]  

  • 24. Epidermolysis bullosa acquisita in childhood. Differentiation from hereditary epidermolysis bullosa.
    McCuaig CC; Chan LS; Woodley DT; Rasmussen JE; Cooper KD
    Arch Dermatol; 1989 Jul; 125(7):944-9. PubMed ID: 2662910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa dystorphica and systemic lupus erythematosus.
    Archibald GC
    Proc R Soc Med; 1976 Dec; 69(12):881-3. PubMed ID: 1013124
    [No Abstract]   [Full Text] [Related]  

  • 26. Self-assessment mini-program.
    Osment LS
    Int J Dermatol; 1978; 17(1):65-6. PubMed ID: 627443
    [No Abstract]   [Full Text] [Related]  

  • 27. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunopathology of epidermolysis bullosa acquisita.
    Kushniruk W
    Can Med Assoc J; 1973 May; 108(9):1143-6. PubMed ID: 4574408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer.
    Furue M; Iwata M; Yoon HI; Kubota Y; Ohto H; Kawashima M; Tsuchida T; Oohara K; Tamaki K; Kukita A
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):873-8. PubMed ID: 3086389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A in epidermolysis bullosa acquisita.
    Zachariae H
    J Am Acad Dermatol; 1987 Dec; 17(6):1058-9. PubMed ID: 3429719
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.
    Woodley DT; Gammon WR
    Cutis; 1983 Dec; 32(6):521-7. PubMed ID: 6357643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearing of epidermolysis bullosa acquisita with cyclosporine.
    Layton AM; Cunliffe WJ
    J Am Acad Dermatol; 1990 Mar; 22(3):535-6. PubMed ID: 2312839
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of epidermolysis bullosa acquisita with cyclosporine.
    Connolly SM; Sander HM
    J Am Acad Dermatol; 1987 Apr; 16(4):890. PubMed ID: 3571559
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus.
    Boh E; Roberts LJ; Lieu TS; Gammon WR; Sontheimer RD
    J Am Acad Dermatol; 1990 Apr; 22(4):587-93. PubMed ID: 2319019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A.
    Merle C; Blanc D; Zultak M; van Landuyt H; Drobacheff C; Laurent R
    Dermatologica; 1990; 181(1):44-7. PubMed ID: 2394303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis.
    Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM
    Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: epidermolysis bullosa acquisita.
    Purdy MJ; Fairbrother GE
    Australas J Dermatol; 1972 Apr; 13(1):27-30. PubMed ID: 5082493
    [No Abstract]   [Full Text] [Related]  

  • 38. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of collagenase inhibition on bullous eruption and healing process in epidermolysis bullosa].
    Coradello H; Lubec G
    Hautarzt; 1979 Feb; 30(2):89-91. PubMed ID: 217851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.
    Chelliah MP; Zinn Z; Khuu P; Teng JMC
    Pediatr Dermatol; 2018 Jul; 35(4):e224-e227. PubMed ID: 29786144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.